See more : MFEC Public Company Limited (MFEC.BK) Income Statement Analysis – Financial Results
Complete financial analysis of JMS Co.,Ltd. (7702.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of JMS Co.,Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Income Statement Analysis – Financial Results
- F45 Training Holdings Inc. (FXLV) Income Statement Analysis – Financial Results
- Fino Payments Bank Limited (FINOPB.NS) Income Statement Analysis – Financial Results
- SI Capital & Financial Services Limited (SICAPIT.BO) Income Statement Analysis – Financial Results
- Induction Healthcare Group PLC (INHC.L) Income Statement Analysis – Financial Results
JMS Co.,Ltd. (7702.T)
About JMS Co.,Ltd.
JMS Co.,Ltd. manufactures, sells, exports, and imports medical devices and pharmaceuticals in Japan and internationally. The company offers infusion and transfusion sets, infusion sets with a needleless access port, disposable needles and syringes, safety scalp vein sets, safety venous indwelling catheters, extension tubes, oral/enteral nutrition systems, infusion and syringe pumps, semisolid nutrition feeding devices, blood bags, blood collection scale and mixers, high-frequency tube sealers, and serum collection sets for infusion and transfusion therapy. It also provides general medical supplies, including latex surgeon's gloves and examination gloves, plastic gloves, treatment sheets, surgical gowns, masks and caps, drainage bags, and surgical tapes used in medical institutions. In addition, the company offers central dialysate delivery systems, hemodialysis machines, AV fistula needles, accidental needlestick prevention systems, hemodialysis blood tubing sets, dialyzers, prefilled syringes, hemodialysis kits, single patient dialysis machines, dialysis solution for CAPD, and automatic peritoneal dialysis machines for hemodialysis and peritoneal dialysis. Further, it provides cardiovascular therapy products, such as cardiopulmonary equipment, membrane oxygenators, heat exchangers, pacemakers, microcatheters, and cardiopulmonary blood tubing sets. JMS Co.,Ltd. was incorporated in 1947 and is headquartered in Hiroshima, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 65.29B | 63.74B | 58.17B | 57.58B | 58.57B | 58.06B | 56.52B | 55.57B | 57.64B | 55.40B | 53.86B | 49.07B | 46.84B | 45.59B | 45.12B | 44.40B | 43.55B |
Cost of Revenue | 51.20B | 49.15B | 43.90B | 42.48B | 42.93B | 43.24B | 42.24B | 41.14B | 42.77B | 41.95B | 40.24B | 35.63B | 34.10B | 32.36B | 31.51B | 31.31B | 30.79B |
Gross Profit | 14.09B | 14.60B | 14.27B | 15.10B | 15.64B | 14.82B | 14.28B | 14.44B | 14.87B | 13.45B | 13.62B | 13.44B | 12.74B | 13.23B | 13.62B | 13.09B | 12.75B |
Gross Profit Ratio | 21.59% | 22.90% | 24.53% | 26.22% | 26.70% | 25.52% | 25.27% | 25.97% | 25.79% | 24.28% | 25.29% | 27.39% | 27.20% | 29.01% | 30.18% | 29.47% | 29.28% |
Research & Development | 1.52B | 1.32B | 1.53B | 1.60B | 1.42B | 1.52B | 1.55B | 1.46B | 1.26B | 1.22B | 1.23B | 1.24B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 10.61B | 10.10B | 9.50B | 9.28B | 13.32B | 13.36B | 13.71B | 9.91B | 10.13B | 9.85B | 9.47B | 8.86B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 1.84B | 2.03B | 1.88B | 1.75B | 1.72B | 1.65B | 1.61B | 1.58B | 1.65B | 1.58B | 1.61B | 1.40B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 12.45B | 12.12B | 11.37B | 11.03B | 13.32B | 13.36B | 13.71B | 11.49B | 11.78B | 11.43B | 11.08B | 10.26B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 399.00M | 179.00M | 295.00M | 105.00M | 143.00M | 117.00M | 131.00M | 228.00M | 12.00M | 179.00M | 78.00M | 52.00M | 78.00M | 46.00M | 138.00M | -14.45M | -417.44M |
Operating Expenses | 14.36B | 13.87B | 13.29B | 12.97B | 13.32B | 13.36B | 13.71B | 13.33B | 13.44B | 13.07B | 12.72B | 11.84B | 11.69B | 11.52B | 11.24B | 11.19B | 11.74B |
Cost & Expenses | 65.56B | 63.01B | 57.19B | 55.45B | 56.25B | 56.60B | 55.95B | 54.47B | 56.21B | 55.02B | 52.96B | 47.47B | 45.78B | 43.88B | 42.75B | 42.51B | 42.53B |
Interest Income | 14.00M | 12.00M | 7.00M | 10.00M | 17.00M | 15.00M | 15.00M | 10.00M | 13.00M | 8.00M | 6.00M | 7.00M | 28.00M | 11.00M | 15.00M | 31.14M | 54.70M |
Interest Expense | 220.00M | 167.00M | 159.00M | 176.00M | 195.00M | 185.00M | 128.00M | 126.00M | 97.00M | 112.00M | 71.00M | 75.00M | 87.00M | 102.00M | 121.00M | 129.41M | 167.37M |
Depreciation & Amortization | 3.71B | 3.59B | 3.36B | 3.24B | 3.16B | 3.04B | 3.06B | 2.97B | 2.69B | 2.52B | 2.25B | 1.72B | 2.57B | 2.61B | 2.48B | 2.24B | 2.39B |
EBITDA | 4.08B | 4.32B | 4.34B | 5.37B | 5.48B | 4.51B | 3.63B | 4.08B | 4.11B | 2.90B | 3.15B | 3.62B | 3.96B | 4.25B | 4.77B | 3.94B | 4.19B |
EBITDA Ratio | 6.25% | 6.82% | 7.98% | 9.43% | 10.22% | 8.37% | 7.09% | 8.19% | 7.01% | 5.43% | 6.51% | 7.48% | 8.63% | 9.96% | 11.16% | 9.26% | 6.25% |
Operating Income | -268.00M | 724.00M | 980.00M | 2.13B | 2.31B | 1.46B | 947.00M | 1.11B | 1.42B | 378.00M | 900.00M | 1.59B | 1.05B | 1.71B | 2.38B | 1.89B | 1.01B |
Operating Income Ratio | -0.41% | 1.14% | 1.68% | 3.69% | 3.95% | 2.52% | 1.68% | 1.99% | 2.47% | 0.68% | 1.67% | 3.25% | 2.25% | 3.74% | 5.27% | 4.26% | 2.33% |
Total Other Income/Expenses | 413.00M | -104.00M | 95.00M | 95.00M | 253.00M | 18.00M | -207.00M | -6.00M | -217.00M | 26.00M | 81.00M | 235.00M | 247.00M | -161.00M | -211.00M | -321.80M | 619.62M |
Income Before Tax | 145.00M | 620.00M | 1.08B | 2.22B | 2.57B | 1.48B | 740.00M | 1.10B | 1.21B | 404.00M | 981.00M | 1.83B | 1.30B | 1.55B | 2.17B | 1.57B | 1.63B |
Income Before Tax Ratio | 0.22% | 0.97% | 1.85% | 3.86% | 4.38% | 2.55% | 1.31% | 1.98% | 2.09% | 0.73% | 1.82% | 3.73% | 2.77% | 3.39% | 4.80% | 3.54% | 3.75% |
Income Tax Expense | 191.00M | 358.00M | 261.00M | 480.00M | 579.00M | 318.00M | 111.00M | -91.00M | 433.00M | 257.00M | 764.00M | 548.00M | 344.00M | 242.00M | 650.00M | 385.46M | 610.00M |
Net Income | -36.00M | 281.00M | 826.00M | 1.74B | 1.98B | 1.16B | 631.00M | 1.18B | 754.00M | 139.00M | 207.00M | 1.28B | 942.00M | 1.29B | 1.51B | 1.18B | 1.02B |
Net Income Ratio | -0.06% | 0.44% | 1.42% | 3.02% | 3.38% | 2.00% | 1.12% | 2.13% | 1.31% | 0.25% | 0.38% | 2.60% | 2.01% | 2.83% | 3.34% | 2.66% | 2.33% |
EPS | -1.47 | 11.50 | 33.81 | 71.12 | 81.08 | 47.59 | 25.89 | 48.50 | 30.93 | 5.70 | 8.49 | 58.80 | 43.65 | 59.82 | 69.68 | 54.57 | 46.95 |
EPS Diluted | -1.47 | 11.50 | 33.81 | 71.12 | 81.08 | 47.59 | 25.89 | 48.50 | 30.93 | 5.70 | 8.49 | 58.80 | 43.65 | 59.82 | 69.68 | 54.57 | 46.95 |
Weighted Avg Shares Out | 24.47M | 24.44M | 24.43M | 24.41M | 24.38M | 24.37M | 24.37M | 24.37M | 24.37M | 24.38M | 24.38M | 21.72M | 21.58M | 21.58M | 21.61M | 21.62M | 21.64M |
Weighted Avg Shares Out (Dil) | 24.47M | 24.44M | 24.43M | 24.41M | 24.38M | 24.37M | 24.37M | 24.37M | 24.37M | 24.38M | 24.38M | 21.72M | 21.58M | 21.58M | 21.61M | 21.62M | 21.64M |
Source: https://incomestatements.info
Category: Stock Reports